Wedbush Analysts Boost Earnings Estimates for NovoCure Limited (NASDAQ:NVCR)

NovoCure Limited (NASDAQ:NVCR – Free Report) – Investment analysts at Wedbush lifted their Q1 2024 earnings estimates for shares of NovoCure in a research report issued on Thursday, February 22nd. Wedbush analyst D. Nierengarten now forecasts that the medical equipment provider will post earnings per share of ($0.36) for the quarter, up from their previous […]

Leave a Reply

Your email address will not be published.

Previous post NV5 Global, Inc. (NASDAQ:NVEE) to Post Q1 2024 Earnings of $0.91 Per Share, William Blair Forecasts
Next post Q1 2024 EPS Estimates for Euroseas Ltd. Reduced by Noble Financial (NASDAQ:ESEA)